Journal
MOLECULAR MEDICINE REPORTS
Volume 13, Issue 1, Pages 333-338Publisher
SPANDIDOS PUBL LTD
DOI: 10.3892/mmr.2015.4528
Keywords
bladder cancer; mammalian target of rapamycin; PP242; cell proliferation; AKT1; S6K1
Categories
Funding
- Liaoning Province Science and Technology Plan Project [2012225016]
- Liaoning Provincial Natural Science Foundation [2013021066]
- Shenyang City Project of Key Laboratory [F13-293-1-00]
Ask authors/readers for more resources
While most cancer types are resistant to mammalian target of rapamycin complex 1 (mTORC1) inhibitor rapamycin, recent studies have identified mTORC2 as an important prospective therapeutic target for cancer. The present study assessed the effects of mTORC2 inhibitor PP242 on the proliferation and migration of bladder cancer cells by using Cell Counting Kit-8, 5-ethyny1-2'-deoxyuridine incorporation, wound healing and Transwell assays. Furthermore, the phosphorylation status of downstream signaling proteins of mTORC1 and mTORC2 was assessed using western blot analysis. The results demonstrated that PP242 concentration-dependently inhibited the proliferation of bladder cancer cells. Simultaneously, the migration ability of bladder cancer cells was suppressed by PP242. In addition, PP242 markedly restrained the phosphorylation of AKT1 and mTORC2, while the phosphorylation status of S6K1 and mTORC1 was not affected. These results suggested that PP242 exerts potent inhibitory effects on bladder cancer cells by modulating the activity of the mTORC2/AKT1 pathway.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available